DCCD (Redistilled for Solid-Phase Synthesis)

CAS : 538-75-0

Ref. 3D-KDC-1023

Informations sur le produit

• Nom: DCCD (Redistilled for Solid-Phase Synthesis)
• Synonymes: Dicyclohexylcarbodiimide, 1,3-Dicyclohexylcarbodiimide, Bis(cyclohexyl)carbodiimide, Carbodiimide, N,N-Dicyclohexyl-, Carbodiimide, dicyclohexyl-, Cyclohexanamine, N,N'-methanetetraylbis-, DCC, Dccd, Dcci, Diciclohexilcarbodiimida, Dicyclohexyl CARBODIMIDE, Dicyclohexylcarbodiimid, N,N'-Dicyclohexyl carbodiimide, N,N'-Dicyclohexylcarbodimide, N,N'-Methanetetraylbis[cyclohexanamine], N,N'-Methanetetraylbiscyclohexanamine, N,N'-dicyclohexyl carbodimide, N,N'-diphenylcarbodiimide, Nsc 30022, Nsc 53373, Nsc 57182

Description

DCCD is a chemical inhibitor of the enzyme pyruvate dehydrogenase kinase that is used to study metabolic pathways. It inhibits the activity of this enzyme by binding reversibly to its active site, thereby blocking its phosphorylation of pyruvate dehydrogenase and thus inhibiting the conversion of pyruvate into acetyl-CoA. DCCD also has been shown to have antidiabetic effects in an experimental model. This drug has been used as a reagent for polymyxin B and other chemical inhibitors in vitro experiments.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 206.33 g/mol
• Formule: C₁₃H₂₂N₂
• Degré de pureté: Min. 95%